Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share. Following this sale, he directly holds 75,691 Common Stock shares. The filing also lists multiple outstanding non-qualified stock options that are vested or scheduled to vest over time, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates extending through 2035. A footnote states the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Vita Coco Company, Inc. director and Executive Chairman Michael Kirban reported an insider transaction involving a trust he is associated with. On the reported date, the Michael Kirban Revocable Trust sold 50,000 shares of common stock at $68.00 per share in an open‑market transaction carried out under a Rule 10b5‑1 trading plan. Following this sale, that revocable trust held 515,681 shares of Vita Coco common stock. Separately, the filing shows 1,479,049 shares of common stock held indirectly by the Michael Kirban 2010 Trust and 143,799 shares held directly, along with several blocks of non‑qualified stock options with exercise prices ranging from $10.178 to $32.78 per share and expirations between 2029 and 2035.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth executed an exercise-and-sell trading pattern under a Rule 10b5-1 trading plan. On April 29–30, 2026, he exercised options to acquire 60,000 shares of common stock at an exercise price of about $10.178 per share and sold 60,000 shares in open-market transactions at prices ranging from $62.50 to $67.50 per share. Following these transactions, he directly owns 57,910 shares of common stock and retains several non-qualified stock option awards with exercise prices between $10.178 and $33.36 per share expiring between 2030 and 2035.
COCO filing discloses resale activity and a restricted stock vesting. The record shows a restricted stock vesting of 2,000 shares on 11/27/2024 issued as compensation. It also lists two resale transactions by Charles Van Es: 2,000 shares sold for $115,960 on 03/16/2026 and 2,000 shares sold for $97,340 on 04/01/2026.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire a total of 45,544 shares of common stock at an exercise price of $10.178 per share, then sold the same 45,544 shares in open-market transactions on two days at weighted average prices of $51.13 and $59.348 per share.
The filing states that these sales were effected under a Rule 10b5-1 trading plan. Following the transactions, Roper directly holds 298,484 shares of common stock. The filing also lists indirect holdings in shares held by his spouse and several Exempt Family Trusts, as well as multiple remaining non-qualified stock option awards with exercise prices ranging from $10.178 to $32.78 and expirations extending to 2035.
COCO affiliate filed a Form 144 proposing sale of 20,000 shares of Common Stock. The filing lists a 20,000-share sale dated 04/30/2026 tied to an option granted 02/10/2020. The record also shows insider sales by Jonathan Burth of 60,000 and 40,000 shares on 03/16/2026 and 04/29/2026, respectively.
The issuer COCO filed a Form 144 notice reporting proposed and recent sales of Common Stock by affiliated holders and a trust. The filing lists a 50,000-share block associated with Fidelity Brokerage Services and two reported sales by the Michael Kirban Revocable Trust of 9,796 shares on 03/11/2026 and 40,204 shares on 03/12/2026.
COCO reported a Rule 144 notice showing 40,000 shares of Common Stock to be sold by Fidelity Brokerage Services LLC on 04/29/2026 for $2,550,000. The filing also records that Jonathan Burth sold 60,000 shares on 03/16/2026 for $3,519,200. The sale is linked to an option granted on 02/10/2020 and the planned sale method is cash.
COCO affiliate reports proposed sale of Common Stock under Form 144. The filing lists multiple proposed or completed dispositions by Martin F. Roper, including repeated blocks of 25,000 shares on several dates in April 2026 and a single 4,456-share sale on 04/13/2026. Transaction prices shown include $1,250,000.00 and similar proceeds for the 25,000-share blocks.
The Vita Coco Company delivered strong Q1 2026 growth and profitability. Net sales rose to $179.8 million, up 37.3% year over year, driven mainly by higher Vita Coco coconut water volumes in both the Americas and International segments.
Gross profit increased to $71.8 million, with gross margin expanding to 39.9% as improved pricing and lower ocean freight more than offset higher finished goods, logistics costs, and legacy tariffs. Net income grew to $30.5 million, with diluted EPS of $0.50, up from $0.31.
Cash and cash equivalents reached $201.9 million with no borrowings on the $60 million Credit Facility, while operating cash flow improved to $15.6 million. The company repurchased 225,273 shares for $11.5 million in Q1 and a further 173,618 shares after quarter-end, and continues to face tariff uncertainty and customer and supplier concentration risks.